[HTML][HTML] Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

…, M Kuehnel, A Haverich, T Welte… - … England Journal of …, 2020 - Mass Medical Soc
Background Progressive respiratory failure is the primary cause of death in the coronavirus
disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of …

[HTML][HTML] Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

…, M Pfeifer, L Grabenhenrich, T Welte… - The Lancet …, 2020 - thelancet.com
Background Nationwide, unbiased, and unselected data of hospitalised patients with COVID-19
are scarce. Our aim was to provide a detailed account of case characteristics, resource …

[HTML][HTML] Intensive insulin therapy and pentastarch resuscitation in severe sepsis

…, S John, R Rossaint, T Welte… - … England Journal of …, 2008 - Mass Medical Soc
Background The role of intensive insulin therapy in patients with severe sepsis is uncertain.
Fluid resuscitation improves survival among patients with septic shock, but evidence is …

Weaning from mechanical ventilation

…, M Stanchina, A Vieillard-Baron, T Welte - European …, 2007 - Eur Respiratory Soc
Weaning covers the entire process of liberating the patient from mechanical support and from
the endotracheal tube. Many controversial questions remain concerning the best methods …

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

…, KB Kristoffersen, O Burkhardt, T Welte… - … ‐Based Child Health …, 2013 - Wiley Online Library
Background Acute respiratory infections (ARIs) comprise a large and heterogeneous group
of infections including bacterial, viral and other aetiologies. In recent years, procalcitonin ‐ …

[HTML][HTML] COPD in never smokers: results from the population-based burden of obstructive lung disease study

…, MA McBurnie, WM Vollmer, G Gudmundsson, T Welte… - Chest, 2011 - Elsevier
Background Never smokers comprise a substantial proportion of patients with COPD. Their
characteristics and possible risk factors in this population are not yet well defined. Methods …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

…, M Seckel, J Sevransky, CL Sprung, T Welte… - Critical care …, 2021 - journals.lww.com
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

…, R Rossaint, F Stuber, N Weiler, T Welte… - Intensive care …, 2007 - Springer
Objective To determine the prevalence and mortality of ICU patients with severe sepsis in
Germany, with consideration of hospital size. Design Prospective, observational, cross-…

European Respiratory Society guidelines for the management of adult bronchiectasis

…, R Wilson, J Vilaró, B Stallberg, T Welte… - European …, 2017 - Eur Respiratory Soc
Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo …

…, N Kahn, S Tello, J Freise, T Welte… - The Lancet …, 2021 - thelancet.com
Background Pirfenidone has been shown to slow disease progression in patients with
idiopathic pulmonary fibrosis (IPF). However, there are few treatment options for progressive …